Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2026)

Jazz Pharmaceuticals' Other financing activities history runs 15 years deep, the most recent figure standing at $32.9 million for Q1 2026.

• In Q1 2026, Other financing activities rose 186.09% year-over-year to $32.9 million; the TTM figure through Mar 2026 stood at $129.3 million (up 308.38% YoY), while the FY2025 annual figure was $107.9 million, up 422.41% from the prior year.
• Other financing activities for Q1 2026 stood at $32.9 million, down from $85.2 million in the prior quarter.
• The five-year high for Other financing activities was $85.2 million in Q4 2025, with the low at $17000.0 in Q3 2024.
• The 5-year median for Other financing activities is $10.9 million (2024), against an average of $18.0 million.
• The sharpest annual moves came in 2024 and 2025: Other financing activities sank 99.69% in 2024, then surged 4211.76% in 2025.
• Jazz Pharmaceuticals' Other financing activities stood at $30.2 million in 2022, then slumped by 70.64% to $8.9 million in 2023, then grew by 3.87% to $9.2 million in 2024, then surged by 826.34% to $85.2 million in 2025, then plunged by 61.38% to $32.9 million in 2026.
• Business Quant data shows JAZZ's Other financing activities at $32.9 million in Q1 2026, $85.2 million in Q4 2025, and $733000.0 in Q3 2025.